Here we use an FBDD approach using nucleic magnetic resonance (NMR) and X-ray crystallography to generate a new family of non-peptidic, small-molecule cyclophilin inhibitors, unrelated to CsA or SfA, with potent in vitro PPIase inhibitory activity and antiviral activity against several families of viruses responsible for frequent human infections. This evidence concerns the gene PPIB and infection.